Comparison of CT-guided thoracic sympathetic nerve block and radiofrequency in the treatment of primary palmar hyperhidrosis.
autonomic nerve block
hyperhidrosis
nerve block
palmar
radiofrequency therapy
sympathetic
Journal
Frontiers in surgery
ISSN: 2296-875X
Titre abrégé: Front Surg
Pays: Switzerland
ID NLM: 101645127
Informations de publication
Date de publication:
2023
2023
Historique:
received:
18
12
2022
accepted:
16
05
2023
medline:
16
6
2023
pubmed:
16
6
2023
entrez:
16
6
2023
Statut:
epublish
Résumé
Primary palmar hyperhidrosis (PPH) is a condition marked by an overactive secretion of the hand's exocrine glands and is frequently hereditary. The profuse sweating associated with this condition can significantly impair the patient's daily activities and quality of life. The objective of this study was to compared the benefits and drawbacks of thoracic sympathetic block and thoracic sympathetic radiofrequency in the treatment of PPH. A retrospective analysis was conducted on 69 patients. They were divided into groups A and B according to their treatment. Group A (34 cases) received CT-guided percutaneous thoracic sympathetic nerve chain anhydrous alcohol chemical damage block, and group B (35 cases) received CT-guided percutaneous thoracic sympathetic nerve chain radiofrequency thermocoagulation. Palmar sweating disappeared immediately after the operation. The recurrence rates at 1, 3, 6, 12, 24, and 36 months were 5.88% vs. 2.86% ( Both methods were found to be effective in treating PPH, but thoracic sympathetic radiofrequency had a longer-term effect, a lower recurrence rate, and a lower incidence of intercostal neuralgia and compensatory hyperhidrosis than a thoracic sympathetic block.
Sections du résumé
Background
UNASSIGNED
Primary palmar hyperhidrosis (PPH) is a condition marked by an overactive secretion of the hand's exocrine glands and is frequently hereditary. The profuse sweating associated with this condition can significantly impair the patient's daily activities and quality of life.
Objective
UNASSIGNED
The objective of this study was to compared the benefits and drawbacks of thoracic sympathetic block and thoracic sympathetic radiofrequency in the treatment of PPH.
Methods
UNASSIGNED
A retrospective analysis was conducted on 69 patients. They were divided into groups A and B according to their treatment. Group A (34 cases) received CT-guided percutaneous thoracic sympathetic nerve chain anhydrous alcohol chemical damage block, and group B (35 cases) received CT-guided percutaneous thoracic sympathetic nerve chain radiofrequency thermocoagulation.
Results
UNASSIGNED
Palmar sweating disappeared immediately after the operation. The recurrence rates at 1, 3, 6, 12, 24, and 36 months were 5.88% vs. 2.86% (
Conclusion
UNASSIGNED
Both methods were found to be effective in treating PPH, but thoracic sympathetic radiofrequency had a longer-term effect, a lower recurrence rate, and a lower incidence of intercostal neuralgia and compensatory hyperhidrosis than a thoracic sympathetic block.
Identifiants
pubmed: 37325414
doi: 10.3389/fsurg.2023.1126596
pmc: PMC10264635
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1126596Informations de copyright
© 2023 Zhang, Xu, Liu, Zhao, Ma and Haung.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Zhonghua Yi Xue Za Zhi. 2017 Dec 12;97(46):3624-3627
pubmed: 29275604
Surg Endosc. 2022 May;36(5):3585-3591
pubmed: 34426874
Clin Radiol. 2013 Dec;68(12):1227-32
pubmed: 23969155
Thorac Cardiovasc Surg. 2022 Mar;70(2):152-158
pubmed: 33860510
Intern Med J. 2021 Sep;51(9):1517-1521
pubmed: 34541778
Clin Auton Res. 2020 Apr;30(2):111-120
pubmed: 31552511
Aesthet Surg J. 2019 Nov 13;39(12):1390-1399
pubmed: 30535166
J Clin Neurosci. 2016 Dec;34:89-93
pubmed: 27473024
Sao Paulo Med J. 2022 Mar-Apr;140(2):284-289
pubmed: 35195234
Surgery. 2019 Dec;166(6):1092-1098
pubmed: 31378477
Indian J Dermatol. 2016 Mar-Apr;61(2):234
pubmed: 27057039
J Vasc Interv Radiol. 2017 Jun;28(6):877-885
pubmed: 28366656
Med Sci Monit. 2019 Oct 02;25:7391-7395
pubmed: 31576813
J Am Acad Dermatol. 2004 Aug;51(2):274-86
pubmed: 15280848
J Am Acad Dermatol. 2019 Sep;81(3):669-680
pubmed: 30710603
Rofo. 2021 May;193(5):574-581
pubmed: 33348382
Wideochir Inne Tech Maloinwazyjne. 2020 Sep;15(3):488-495
pubmed: 32904609
Ann Dermatol. 2017 Dec;29(6):728-734
pubmed: 29200761
Neurologia. 1995 Feb;10(2):101-3
pubmed: 7695936
Pain Physician. 2019 Nov;22(6):591-599
pubmed: 31775406
Clin Auton Res. 2015 Apr;25(2):105-8
pubmed: 25381140
Clin Auton Res. 2014 Jun;24(3):143-9
pubmed: 24740713
J Drugs Dermatol. 2018 Jul 1;17(7):707-714
pubmed: 30005091
Australas J Dermatol. 2017 May;58(2):e31-e35
pubmed: 27029500
Clin Auton Res. 2021 Aug;31(4):511-528
pubmed: 33772671
Med Sci Monit. 2021 Jan 12;27:e928209
pubmed: 33434188
Surgeon. 2010 Oct;8(5):287-92
pubmed: 20709287
J Am Acad Dermatol. 2020 Apr;82(4):969-979
pubmed: 31811879